Research examines the stability of SARS-CoV-2 variants in aerosols, finding significant decay in infectivity over time. pH and salt content play a role in virus stability.
MSD mulls 2025/26 launch for RSV vaccine after Phase II/III win
Clesrovimab is a single dose extended half-life monoclonal antibody developed as a passive immunisation for the prevention of RSV. Image credit: Sergiy Palamarchuk / Shutterstock.